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Proinflammatory T helper 17 (Th17) cells control infections caused by microbial pathogens. Surprisingly,
several recent reports now reveal that symbiotic gut bacteria modulate Th17 cell differentiation and function
in the gastrointestinal tract. As various autoimmune and allergic disorders aremediated by uncontrolled T cell
responses, immune regulation by the microbiota may have direct implications for human health.Immune Responses to Gut Bacteria
The mammalian immune system is a remarkable and dynamic
organ, responsible for many fundamental aspects of health
and disease. Its primary task is to recognize microbial molecules
and mount appropriate and specific immune responses. It has
been historically viewed that immune reactions to bacteria occur
mainly during infections. However, based on more recent work
we now know that even normal immune system development
depends on specific direction from symbiotic bacteria (Mac-
pherson and Harris, 2004).
The gastrointestinal tract provides residence to an astounding
number of microbial species, which have profound effects on
host biology and physiology (Backhed et al., 2005). Symbiotic
bacteria of the mammalian gut have long been appreciated
for the benefits they provide to the host, including provision
of essential nutrients, metabolism of indigestible compounds,
defense against colonization by opportunistic pathogens, and
even contributions to the development of the intestinal architec-
ture (Hooper and Gordon, 2001). Recent studies have shown
that symbiotic bacteria synthesize immunomodulatory mole-
cules that guide maturation of the immune system (Mazmanian
et al., 2005); one result of this interaction is protection from intes-
tinal inflammation (Mazmanian et al., 2008). Thus, it appears that
certain gut bacteria have evolved mechanisms to improve host
health by modulating intestinal immune responses.
As a key component of the adaptive immune system, CD4+
T cells are required for vital functions ranging from controlling
infectious agents to the regulation of autoimmune reactions
and cancers. Effector CD4+ T cells are generally divided into
three subtypes: T helper 1 (Th1), Th2, and Th17 (Figure 1). These
three lineages are responsible for carrying out distinct and
opposing activities that are mediated by their unique cytokine
repertoires. The proper balance of immunologic responses
between T helper subsets has been shown to be critical to the
overall health of humans and animals (Steinman, 2007). For
example, elevated proportions of Th1/Th17 cells lead to inflam-
matory bowel disease and autoimmunity (e.g., multiple sclerosis,
rheumatoid arthritis, psoriasis), while increased expression of
Th2 cytokines is associated with asthma and other allergic disor-
ders. Whereas Th1 and Th2 cells have been studied for about
two decades, Th17 cells that produce the potent inflammatory8 Cell Host & Microbe 5, January 22, 2009 ª2009 Elsevier Inc.cytokine interleukin-17 (IL-17) have been identified in only the
last few years (Bettelli et al., 2006; Weaver et al., 2007). Now,
a series of recent reports suggest that the differentiation of intes-
tinal Th17 cells and their balance with anti-inflammatory regula-
tory T cells (Tregs) critically depends on the intestinal microbiota
(Figure 1). Based on the involvement of Th17 cells in various
inflammatory conditions, understanding how and more impor-
tantly why gut bacteria influence this specific T cell lineage
may have significant implications for human health.
TheMicrobiota Shape Intestinal Th17 Cell Development
IL-17 production is controlled by the orphan nuclear receptor
RORgt (retinoic acid-related orphan receptor), widely consid-
ered the ‘‘master regulator’’ of Th17 cell differentiation (Ivanov
et al., 2006). Using an RORgt-GFP reporter mouse, Littman
and colleagues demonstrate that IL-17-expressing CD4+
T cells are preferentially enriched in the small intestinal lamina
propria relative to other tissues (Ivanov et al., 2008). Though
several other sites did contain RORgt+ cells, the vast majority
of nonintestinal IL-17-producing cells were not TCRab+CD4+
T cells, indicating that most ‘‘classical’’ Th17 cells are in the
gut. In order to understand the timeframe for Th17 cell develop-
ment, the authors measured IL-17 expression from various
stages during ontogeny. IL-17 production from CD4+ T cells of
the small intestine was absent from newborn mice, but steadily
increased from birth to postweaning. As mammals are born
sterile and subsequently initiated into an organized program
of colonization by symbiotic bacteria (Palmer et al., 2007), could
it be possible that the intestinal microbiota plays a role in
Th17 cell development?
Over four decades of germ-free (GF) animal research have
shown that genetically wild-type animals display numerous
defects in both cellular and morphologic development of the
immune system in the absence of microbiota (reviewed in Mac-
pherson and Harris [2004]). Ivanov et al. explored the hypothesis
that microbial colonization after birth induces the generation of
intestinal Th17 cells by first examining IL-17 production by
CD4+ T cells inGFanimals. Surprisingly, animals devoid ofmicro-
bial (bacterial, viral, fungal, and protozoan) colonization were
dramatically deficient in the production of IL-17 fromTCRb+CD4+
cells of the small intestinal lamina propria (Ivanov et al., 2008).
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suggesting that the lack of Th17 cells was not due to an overall
deficiency in immune activation, and that specific features of
the immune response are sensitive to the microbiota. Moreover,
TCRb+Th17cells from laminapropria lymphocytes (LPLs) appear
to represent the major source of IL-17, as levels of the Il17 tran-
script are greatly reduced in GF intestines compared to those
of colonized animals. When GF animals were reconstituted with
the microbiota of SPF (specific pathogen-free) animals,
IL-17production in the small intestine returned as theproportions
of Th17 cells increased gradually over several weeks. In contrast
to the finding that GF animals are deficient in intestinal IL-17
Figure 1. T Helper Lineage Differentiation Is a Dynamic Process that
Is Influenced by the Intestinal Microbiota
CD4+ T helper cells can differentiate into proinflammatory (T helper 1 [Th1],
Th2, or Th17) cells or anti-inflammatory regulatory T (Treg) cells. Th1 cells
are characterized by their secretion of interferon-g (IFNg), and function
to control infections by intracellular pathogens (i.e., viruses and bacteria).
Th2 cells secrete IL-4, IL-5, and IL-13, and mediate immune responses to
extracellular pathogens (i.e., parasites and bacteria). Th17 cells secrete
IL-17, IL-21, and/or IL-22, and are believed to respond following infection by
extracellular pathogens (i.e., fungi and bacteria). However, proinflammatory
immune responses need to be regulated, as uncontrolled or elevated reactions
will result in collateral damage to host tissues. Increased and prolonged Th1/
Th17 responses are believed to drive autoimmune diseases such as multiple
sclerosis, type 1 diabetes, rheumatoid arthritis, and psoriasis. Th2 responses,
when left unchecked, may underlie the development of asthma and several
allergic disorders. Proinflammatory immune reactions are controlled by regu-
latory T cells, which secrete factors such as IL-10 and TGFb, and through other
mechanisms that are still not well defined, limit T helper responses either
following pathogen clearance or during the steady state. The current view of
T helper differentiation posits that each of these lineages is distinct, and
defined by gene regulatory networks encoded by the mammalian genome
during T cell development. Recent studies are now suggesting that the distinc-
tion between each lineage fate is not predetermined, and may be adaptable.
For example, the ratios between Th17 and Treg cell differentiation in the colon
may be influenced by the intestinal microbiota, perhaps through modulation
of their respective transcription factors, RORgt and Foxp3. Therefore,
improper modulation of the balance between pro- and anti-inflammatory cell
responses can lead to immune disorders, potentially linking the microbiota
to noninfectious diseases.expression, Zaph et al. observed equivalent proportions of
IL-17+ CD4+ T cells in the small intestine of GF animals (Zaph
et al., 2008). The basis for the discrepancies appears enigmatic,
as animal strains, housing conditions, and experimental
approaches seem to be comparable between studies. However
collectively, it appears that the microbiota modulates steady-
state immune responses by either positively or negatively influ-
encing Th17 cell development. The finding that intestinal
microbes modulate IL-17 expression by intestinal CD4+ T cells
represents an important aspect of T helper cell biology that was
previously unappreciated.
Subsets of Bacterial Populations Affect T Helper
Profiles
The identity of bacterial species that modulate ‘‘homeostatic’’
IL-17 production is currently unknown, but Ivanov et al. have
begun to address this issue based on a very intriguing observa-
tion. SPF mice from Jackson Laboratory display greatly reduced
percentages of IL-17+ T cells compared to SPF mice from
Taconic Farms, even though the genotypes are identical (Ivanov
et al., 2008).When animals fromeach vendorwere cohoused, the
proportions of Th17 cells among small intestinal LPLs of Jackson
Laboratory mice were restored. As SPF mice from each source
contain diverse but different microbiotas, this argues that partic-
ular subsets of bacteria are specifically involved in IL-17 produc-
tion and that IL-17 production is not a result of general bacterial
colonization. In support of this notion, transplantation of gut
bacteria from Taconic mice into GF recipients restored their
defect in Th17 cell numbers, whereas bacteria from Jackson
Laboratory mice did not. The microbiome of both mice and
man are dominated by two phyla (over 90%belong to either Bac-
teroidetes or Firmicutes) (Ley et al., 2008). Molecular analysis
indicated that Jackson mice were not colonized with Bacteroi-
detes (formerly known asCytophaga-Flavobacteria-Bacteroides
[CFB]), and treatmentwith antibiotics that reducedBacteroidetes
colonization in Taconic mice led to a reduction in IL-17 produc-
tion by CD4+ T cells. These studies suggest a profound hypoth-
esis: Th17 cell differentiation is directed by specific classes of
bacteria in a dynamic and reversible manner. If true, then alter-
ations in the microbial community could alter IL-17 production
in the gut, having significant implications for intestinal (and
perhaps nonintestinal) inflammatory diseases.
Potential Mechanisms by which Bacteria Modulate Gut
Immune Profiles
The mechanism of microbiota-mediated Th17 cell differentiation
was recently addressedbyTakeda andcolleagues,who reported
that adenosine 50-triphosphate (ATP) is sufficient to increase
IL-17 production from CD4+ T cells (Atarashi et al., 2008). Inves-
tigating T helper cell phenotypes among LPLs of the colon, Atar-
ashi et al. revealed that GF animals display a reduction in colonic
IL-17 levels and fecal ATP concentrations. They also show that
intestinal bacteria secrete copious amounts of ATP. Signaling
through ATP sensors, long known to be involved in enteric
nervous system function, has recently been shown to induce
the expression of IL-23 from dendritic cells (Schnurr et al.,
2005). As IL-23 is involved in the expansion and maintenance of
the Th17 cell lineage, the authors speculated that ATP produced
by themicrobiotamaybecritical for IL-17 expressionby intestinalCell Host & Microbe 5, January 22, 2009 ª2009 Elsevier Inc. 9
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tionofATP toGFmice resulted in an increase inTh17proportions,
and treatment of SPF mice with apyrase (which cleaves ATP) led
to a decrease in the percentages of IL-17-producingCD4+ T cells
in colonic LPLs. It is intriguing that intraperitoneal injection of ATP
led to an increase in colonic IL-17 levels and raises questions
regarding tissue specificity (Were other anatomical locations
also affected by systemic ATP treatment? Does ATP influence
lymphocyte homing to the gut?). However, cytokine responses
seem to be specific. Although GF animals are reduced in inter-
feron-g (IFNg) production, ATP did not affect the expression of
IFNg, which is the canonical cytokine produced by Th1 cells.
These observations suggest that different molecular signals
(possibly produced by distinct members of the microbiota)
mediate differential T helper cell phenotypes during intestinal
colonization. A recent study similarly reported that gut bacteria
mediate IL-17 and IFNg production in the colon, though the role
of ATP was not investigated (Niess et al., 2008). Consistent with
the notion that ATP may be acting on intestinal dendritic cells
(DCs), conditioned media from cultures of intestinal bacteria
(but not pathogenic bacteria)was able to induce IL-17production
by CD4+ T cells during in vitro CD11c+ DC-T cell cocultures.
Treatment of the conditioned media with apyrase abolished this
activity, strongly suggesting that ATP, and not another bacterially
produced factor, is required for Th17 cell differentiation. The
same conditioned media that induced IL-17 expression did not
increase IFNg levels in the coculture system, demonstrating
that ATP does not affect the differentiation of TH1 cells. Using
an antibiotic treatment regimen to target specific classes of
bacteria, Atarashi et al. also show that fecal ATP concentrations
are lowered along with Th17 cell proportions. Collectively, these
findings imply that specific members of the microbiota may
preferentially produce ATP, which ultimately promotes IL-17
expression in the colon of experimental animals.
The intestinal symbiotic bacteria are separated from the gut-
associated lymphoid tissues (GALT) by a single layer of intestinal
epithelial cells. Correspondingly, epithelial cell responses to
nonpathogenic gut bacteria may impact the nature and develop-
ment of intestinal immune responses. Artis and colleagues
recently investigated the contributions of the microbiota on
intestinal epithelial cell (IEC) regulation of Th17 development
(Zaph et al., 2008). Their studies indicate that the proportions
of colonic (and cecal patch) Th17 cells were elevated in GF
animals compared to SPF animals, which displayed nominal
levels of IL-17. This finding was consistent in at least two strains
of mice (C57BL/6 and BALB/c). Zaph et al. further show that
levels of IL-23, in addition to those of IL-17, are increased in
colonic tissues of GF mice. As IL-23 is known to be required
for maintenance of the Th17 phenotype, the authors speculate
that inhibition of IL-23 expression by the microbiota reduces
IL-17 production. Accordingly, the IECs of GF animals are defi-
cient in the expression of IL-25, a known inhibitor of IL-23. Treat-
ment of GF mice with IL-25 reduced IL-17 and IL-23 expression
in the colon, whereas IL-25/ animals displayed increased
IL-17 and IL-23 levels. Although we do not know the identity of
the IL-25-inducing microorganism(s), these data suggest that
the microbiota may signal through IECs to regulate the develop-
ment of colonic TH17 cells. Though an extensive analysis is
beyond the scope of this review, the role of epithelial cells in10 Cell Host & Microbe 5, January 22, 2009 ª2009 Elsevier Inc.mediating ‘‘communication’’ between the microbiota and the
innate and adaptive immune system is an emerging and exciting
field of research.
Regulatory T Cells Respond to Microbial Products
to Balance T Helper Responses
A healthy immune system is designed to balance inflammatory
responses with suppressive mechanisms to limit collateral
damage to tissues. Many studies have identified a reciprocal
relationship between inflammation mediated by T helper cells
and anti-inflammatory regulatory T cell (Treg) responses (Bettelli
et al., 2006). Foxp3 (forkhead box P3) is a Treg lineage specific
transcription factor that can induce regulatory phenotypes and
immunosuppressive functions by CD4+ T cells (Fontenot et al.,
2005). Defects in Foxp3 Treg activity (such as by mutations in
the foxp3 gene) cause severe multiorgan lymphoproliferative
disease in both humans and animals (Foussat et al., 2003).
Previous studies have identified a critical role for Foxp3+ Tregs
in controlling intestinal inflammation, and Ivanov et al. report
that Tregs are proportionally increased in LPLs of GF animals
(simultaneous with a decrease in Th17 cells) (Ivanov et al.,
2008). Accordingly, Belkaid and colleagues investigated if micro-
biota influence the equilibrium between effector T cells and regu-
latory T cells in the gut. Toll-like receptors (TLRs) are well known
to modulate intestinal inflammation, and TLR9 signaling can limit
Treg suppression. The authors observed that Tlr9/ animals
(reared under SPF conditions) contained increased proportions
of Foxp3+ T cells in various gut tissues, most notably in the
lamina propria of the small intestine (Hall et al., 2008). Concom-
itantly, the levels of IFNg and IL-17 were markedly decreased
among CD4+ T cells of Tlr9/ animals in multiple intestinal
tissues. Thus, signaling through TLR9 appears to reciprocally
modulate the equilibrium between effector T cells and regulatory
T cells. Hall et al. go on to show that engagement of TLR9 with
the model ligand CpG (a microbial DNA mimic) inhibits naive
T cell differentiation into Tregs, and the same effect is observed
with DNA extracted from intestinal microbes. Furthermore, cells
from Tlr9/ animals did not respond to gut bacterial DNA. The
authors suggest that intestinal bacteria may be involved in
suppressing Treg cell conversion, and that the absence of
TLR9 limits inflammatory responses due to a defect in ‘‘sensing’’
the microbiota. A role for the microbiota in mediating this
process was demonstrated when administration of antibiotics
resulted in reduced Th1 and Th17 cytokine responses, similar
to that observed in Tlr9/ animals. Gut bacterial DNA given to
antibiotic-treated mice restored the levels of IFNg and IL-17,
suggesting that DNA from the microbiota functions as an adju-
vant to increase homeostatic levels of inflammatory cytokines.
The findings that gut bacteria induce controlled, homeostatic
inflammation may have important consequences, as a mucosal
immune system that is ‘‘primed’’ by the microbiota may be
able to respond more quickly to pathogenic infections. Though
the specificity of the DNA is still uncertain (for example, will
DNA from microbial communities outside the gut have the
same effect?), and the mechanism by which DNA inhibits Treg
conversion is not fully known, Hall et al. provide interesting
potential functions for gut bacteria in modulating intestinal
immune responses.
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A ‘‘balanced’’ equilibrium among T helper cell responses is
required for many aspects of immunologic health. Imbalances
in the composition of the bacterial microbiota, known as dysbio-
sis, are postulated to be a major factor in human disorders such
as inflammatory bowel disease (IBD). To address the impact of
IL-17 production by the microbiota for health, Takeda and
colleagues show that the administration of ATP during the induc-
tion of intestinal inflammation results in increased pathology and
severity of disease (Atarashi et al., 2008). Using an experimental
model of colitis whereby T cells are transferred into severe
combined immunodeficient (SCID) mice, it was shown that
ATP injections led to a specific increase in Th17 cells. This
increase coincided with exacerbation of disease symptoms,
including increases in inflammatory cell infiltration into colonic
tissues, epithelial hyperplasia, and weight loss. However, it
must be considered that the T cell transfer model was performed
in SPF animals, which are known to develop disease as a conse-
quence of uncontrolled immune reactions directed toward the
resident microbiota. Thus, as expected, ATP administration
augmented the disease process by elevating Th17 responses.
As noted by the authors, this experimental approach does not
test the homeostatic function of microbiota-mediated IL-17
production. GF recipient animals do not develop disease when
the same T cells are transferred, and so the biological role for
ATP during Th17 differentiation may be better revealed in the
absence of inflammation induced toward SPF bacteria. As
IL-17 is known to be involved in protection from extracellular
pathogens, challenge of GF mice with enteric pathogens in the
presence or absence of ATPmay help assign a possible function
to Th17 cell differentiation in the gastrointestinal tract.
Though not working in a GF system, Hall et al. explored the
potential that signals from the microbiota may help protect
animals from microbial infections. After showing that antibiotic
treatment of mice led to a decrease in intestinal IL-17 production
(similar to Tlr9/ animals), and that DNA from intestinal bacteria
was sufficient to correct this defect, the authors speculated that
a reduction in IL-17 may impair immune responses that control
intestinal infections (Hall et al., 2008). Infection of antibiotic
treated animals with Encephalitozoon cuniculi, a microsporidial
pathogen that causes severe diarrhea in immunocompromised
people, resulted in an increase in parasite infectivity. Therefore,
similar to studies done in GF mice (Macpherson and Harris,
2004), the microbiota appears to limit enteric infections. More
importantly, administration of gut microbiota DNA to animals
with antibiotics provided protection from E. cuniculi infections,
suggesting that homeostatic restoration of IL-17 levels provides
a health benefit to the host. A control TLR ligand (lipopolysac-
charide; LPS) did not reduce parasite burden, indicating the
specificity of DNA for this process. Therefore, it appears that
a reduction in IL-17 levels (either in GF or antibiotic-treated
animals) may cause immunologic deficiencies and increased
susceptibility to pathogenic infections. These studies bring to
light a new perspective of the microbiota—induction of ‘‘regu-
lated’’ inflammatory processes by gut bacteria may be a means
of actively shaping beneficial immune responses, as opposed to
pathogens which induce acute inflammation to promote the
disease process.Conclusion
The human gastrointestinal tract is home to a complex micro-
bial ecosystem that contains 10-fold more cells than the
human body, encodes for 100 times the number of genes in
the human genome, and possesses the metabolic capacity of
the human liver. Though millions of years of coevolution have
forged the potential for host-bacterial symbiosis, the influence
of this ‘‘forgotten organ’’ on our biology and health is only now
being truly appreciated. Based on clinical, epidemiologic, and
immunologic evidence, it appears that changes in the intestinal
microbiota may be an essential factor in numerous inflamma-
tory disorders. Accordingly, a recent series of articles is begin-
ning to highlight the importance of balancing both the effector
and regulatory arms of the intestinal immune response. These
studies show that the microbiota influences proinflammatory
Th17 cell differentiation through molecular pathways that
may include bacterial DNA, ATP, and signaling through IECs.
Several reports, not described here, have recently revealed
that intestinal bacteria also induce Treg development and func-
tion (though the molecular mechanisms remain a mystery).
Collectively, emerging evidence indicates that a healthy micro-
biota mediates overall ‘‘balance’’ in the immune system, as
opposed to strictly driving pro- or anti-inflammatory responses.
How the microbiota does so is most likely a function of the
community structure—i.e., the microbiota is not a single entity,
but an amalgam of diverse microorganisms with distinct roles.
Some organisms may drive Treg development specifically,
while others only promote Th17 development. Though Th17
cells are required for clearance of extracellular pathogens,
excessive levels of IL-17 are implicated in diseases such as
multiple sclerosis, IBD, psoriasis, lupus, and rheumatoid
arthritis. Therefore, depletion of Treg promoting organisms
and/or overgrowth of microbes that drive Th17 development
may result in a proinflammatory immune profile. Factors that
change the composition of the microbiota (pervasive antibiotic
use, hygiene, high-calorie diets, vaccinations, etc.) could alter
healthy microbial balances resulting in inflammatory disorders.
As Aristotle wrote, ‘‘True virtue lies in moderation.’’ Perhaps
immunologic virtue is lost during dysbiosis, adversely tipping
the balance toward exacerbated inflammation that results in
disease. As the mammalian immune system evolved in the
presence of symbiotic microbes (i.e., mammals were never
germ free), it is very conceivable that some microbes actively
network with the immune system to regulate specific host
responses. If true, then we may have to contemplate the possi-
bility that the human genome does not encode all functions
required for health, and that we depend on crucial interactions
with the human microbiome for our wellbeing.
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